Literature DB >> 12186477

Camptocormia treated with bilateral pallidal stimulation.

Dipankar Nandi1, Simon Parkin, Richard Scott, Jonathan L Winter, Carole Joint, Ralph Gregory, John Stein, Tipu Z Aziz.   

Abstract

The authors report the neurological, neurophysiological, and neuropsychological effects of using long-term bilateral pallidal high-frequency deep brain stimulation (DBS) in a case of disabling camptocormia. Deep brain stimulation electrodes were implanted stereotactically to target the globus pallidus internus (GPi) bilaterally. Local field potentials (FPs) were recorded using the DBS electrodes and concurrent abdominal flexor electromyography (EMG) potentials during camptocormic episodes. Videotaped assessments of the movement disorder and neuropsychological evaluations of the patient before implantation and 6 months after initiation of pallidal stimulation were recorded. There was significant functional improvement following long-term pallidal stimulation, and some improvement was noted in neuropsychological scores. A temporal correlation between the GPi FPs and EMG-recorded rectus abdominis potentials was evident. There were no treatment-related adverse effects. The authors have found that long-term pallidal stimulation was safe and offered functional benefit to a patient with this severely disabling condition. The physiological studies may help further the understanding of the pathophysiology of this rare entity.

Entities:  

Mesh:

Year:  2002        PMID: 12186477     DOI: 10.3171/jns.2002.97.2.0461

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

Review 1.  Deep brain stimulation: current and future clinical applications.

Authors:  Mark K Lyons
Journal:  Mayo Clin Proc       Date:  2011-06-06       Impact factor: 7.616

2.  Repetitive transcranial magnetic stimulation for treatment of tardive syndromes: double randomized clinical trial.

Authors:  Eman M Khedr; Bastawy Al Fawal; Ahmed Abdelwarith; Mostafa Saber; John C Rothwell
Journal:  J Neural Transm (Vienna)       Date:  2018-10-13       Impact factor: 3.575

3.  Camptocormia as a clinical manifestation of mitochondrial myopathy.

Authors:  José A Gómez-Puerta; Pilar Peris; Josep M Grau; M Angeles Martinez; Núria Guañabens
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 2.980

4.  Deep brain stimulation for camptocormia in dystonia and Parkinson's disease.

Authors:  Hans-Holger Capelle; Christoph Schrader; Christian Blahak; Wolfgang Fogel; Thomas M Kinfe; Hansjoerg Baezner; Joachim K Krauss
Journal:  J Neurol       Date:  2010-08-28       Impact factor: 4.849

5.  Pallidal deep brain stimulation relieves camptocormia in primary dystonia.

Authors:  Tim Hagenacker; Marcus Gerwig; Thomas Gasser; Dorothea Miller; Oliver Kastrup; Daniel Jokisch; Ulrich Sure; Markus Frings
Journal:  J Neurol       Date:  2013-03-13       Impact factor: 4.849

Review 6.  [Primary neurogenic and myogenic disorders of posture].

Authors:  C Schranz; H-M Meinck
Journal:  Orthopade       Date:  2004-05       Impact factor: 1.087

7.  Camptocormia and Parkinson's disease: MR imaging.

Authors:  Fabrice Bonneville; Frédéric Bloch; Ewa Kurys; Sophie Tezenas du Montcel; Marie-Laure Welter; Anne-Marie Bonnet; Yves Agid; Didier Dormont; Jean-Luc Houeto
Journal:  Eur Radiol       Date:  2008-03-20       Impact factor: 5.315

Review 8.  Camptocormia: Etiology, diagnosis, and treatment response.

Authors:  Farwa Ali; Joseph Y Matsumoto; Anhar Hassan
Journal:  Neurol Clin Pract       Date:  2018-06

9.  Camptocormia: a rare axial myopathy disease.

Authors:  Samuel Katsuyuki Shinjo; Silvia Carolina Ramos Torres; Ari Stiel Radu
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

10.  Globus Pallidus Internus Deep Brain Stimulation for Dystonic Opisthotonus in Adult-Onset Dystonia: A Personalized Approach.

Authors:  Kantharuby Tambirajoo; Luciano Furlanetti; Michael Samuel; Keyoumars Ashkan
Journal:  Front Hum Neurosci       Date:  2021-06-10       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.